DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/02/2025 12:42 PDT] DiaMedica Therapeutics Inc. (NASDAQ:DMAC), Down By 100% ($6.11) From $6.11 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [08/25/2025 07:19 PDT] DMAC Expected to Trade Down After Bearish Patterns Develop
• [08/07/2025 10:29 PDT] DiaMedica Therapeutics Inc. (NASDAQ:DMAC), Up By 100% ($4.49) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, August 5th 2025 at a Price of $4.49.
• [08/05/2025 11:07 PDT] DMAC SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [08/01/2025 07:17 PDT] DMAC Expected to Trade Down After Bearish Patterns Develop
• [07/28/2025 09:51 PDT] DiaMedica Therapeutics Inc. (NASDAQ:DMAC), Up By 100% ($4.9) After BUYINS.NET SqueezeTrigger Report Released on Monday, July 21st 2025 at a Price of $4.9.
• [07/28/2025 09:51 PDT] DiaMedica Therapeutics Inc. (NASDAQ:DMAC), Up By 100% ($4.6) From $4.6 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [07/23/2025 07:06 PDT] DMAC Expected to Trade Up After Bullish Patterns Develop
• [07/21/2025 10:29 PDT] DMAC SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.